RELATED CONTENT
DRUGOGRAPHY
Home > About AIT > Executive Leadership
Founder, President, and CEO Michael A. Evans, Ph.D. brought twenty years of experience in toxicology and medical training to the forefront when he founded AIT Laboratories in 1990. Since then, the Indianapolis-based reference laboratory, which specializes in pain management, forensics, clinical and pharmaceutical testing, has grown into a premiere testing and research institution recognized nationwide for superior customer service and quality in testing. Prior to his career as an entrepreneur, Evans served as tenured professor, director, faculty member, and researcher for institutions such as the Indiana University School of Medicine, Vanderbilt University Medical Center, Illinois Institute of Technology, and the University of Illinois College of Medicine. He was also a visiting professor of toxicology for Kunming Medical College and the Sichuan Institute of Materia Medica, both located in China.
Evans’ educational background comprises a doctorate in toxicology from the Indiana University School of Medicine, a postdoctoral fellowship with the National Toxicology Center at Vanderbilt University School of Medicine, and numerous fellowships and grants from the National Institute of Health and the World Health Organization. His expertise is frequently sought out for private consultation.
Vice President of Operations Jason Bush, Ph.D. joined AIT Laboratories in October 2010. Bush oversees the operational efficiency and cost effectiveness of AIT’s internal processes from sample collection to receipt of payment receipt.
Bush began his career with AIT as the director of laboratory operations. In this role, he provided leadership to AIT’s laboratory team, making sure they had the tools needed to succeed. Through workflow and staffing model optimization, the laboratory increased capacity without increasing costs or equipment. He aligned department objectives with AIT’s corporate goals and established a formal program for tracking and reporting internal metrics.
Prior to joining AIT, Bush held the position of director of clinical operations at Precision Therapeutics, Inc., a leader in personalized medicine. In this role, he had responsibility for overseeing a clinical laboratory, quality control, process improvement, medical records, and materials management. Bush led the lab through 300-percent growth of sample volume in two years and the construction of an expansion facility.
Bush earned his bachelor’s degree in chemical engineering from the University of Dayton and holds a master’s degree from the University of Pittsburgh. He earned his doctorate in bioengineering/chemical engineering from Carnegie Mellon University.
Vice President, Chief Financial Officer Paula Conroy joined AIT Laboratories in September 2012. In this role, Conroy oversees the accounting, finance and risk management functions for AIT.
Prior to joining AIT, Conroy owned and operated a consulting business specializing in CFO services to privately held companies. Conroy’s extensive career also includes audit, U.S. Securities and Exchange Commission (SEC) and mergers and acquisitions experience. She previously has served in CFO roles in the healthcare sector. Conroy started her career at Ernst & Young LLP and has held positions at other major accounting firms.
Conroy earned a Bachelor of Science in general management from Purdue University, received her Master of Business Administration from the Krannert School of Management at Purdue University and is a certified public accountant. Currently, Conroy is serving as a limited-term lecturer at Purdue University teaching auditing.
Scott LaNeveVice President, Sales and MarketingE-mail: slaneve@aitlabs.com
Vice President of Sales and Marketing, Scott LaNeve, joined AIT Laboratories in February 2013. LaNeve brings to AIT 30 years of general management and commercial leadership experience from a broad spectrum of healthcare companies including Fortune 100 market leaders such as Abbott Laboratories, Roche and Quest Diagnostics.
LaNeve spent the past eight years assisting small start-ups and mid-market companies, concentrating on commercial turnarounds. LaNeve’s extensive experience and knowledge in diagnostics, marketing and global sales uniquely leverages AIT’s performance in every market segment, customer type and commercial challenge found in healthcare.
LaNeve earned his bachelor’s degree in psychology from West Virginia University. He also studied marketing management at Boston University’s overseas graduate program in Germany, finance and accounting at the Columbia University Graduate School of Business in New York and global business management at the Institute for Management Development (IMD) in Switzerland.
In 2001 and 2002, LaNeve served as president of the Diagnostics Marketing Association (DxMA). He is also a U.S. Army Command and General Staff College graduate, a former military officer, paratrooper and combat veteran who served in Europe and Central America.
Andrea Terrell, Ph.D., DABCCVice President, Chief Scientific OfficerE-mail: aterrell@aitlabs.com
Andrea Terrell, Ph.D., DABCC has served as laboratory director since 2003 and vice president, chief scientific officer for AIT Laboratories since 2008. Under Terrell’s leadership, AIT has received certification with the College of American Pathologists (CAP) and American Board of Forensic Toxicology (ABFT) and maintains accreditation with the International Organization for Standardization (ISO) and Clinical Laboratory Improvement Amendments (CLIA).
Terrell is a member of the American Association of Clinical Chemistry (AACC), Society of Forensic Toxicologists (SOFT), Midwest Association of Toxicology and Therapeutic Drug Monitoring, and the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDM-CT). She is also a fellow of the National Academy of Clinical Biochemistry and is board certified in clinical chemistry through the American Board of Clinical Chemistry (ABCC).
Terrell earned her bachelor’s degree in biology from Indiana University and her doctorate in biochemistry and molecular biology from Colorado State University. She also completed a fellowship in clinical chemistry and laboratory medicine at Washington University. She regularly participates in conferences held by AACC, SOFT, and IATDMCT to present on topics related to clinical and forensic toxicology. Terrell was named to Indianapolis Business Journal’s “Forty Under 40” list in 2008 and currently serves on the board of trustees for Marian University and the Indiana chapter of The Nature Conservancy as well as the board of directors for the American Board of Clinical Chemistry.